Annual Operating Expenses
$13.32 M
-$6.39 M-32.42%
01 December 2023
Summary:
Plus Therapeutics annual total operating expenses is currently $13.32 million, with the most recent change of -$6.39 million (-32.42%) on 01 December 2023. During the last 3 years, it has risen by +$3.43 million (+34.73%). PSTV annual operating expenses is now -68.38% below its all-time high of $42.12 million, reached on 31 December 2013.PSTV Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$3.80 M
+$102.00 K+2.76%
01 September 2024
Summary:
Plus Therapeutics quarterly total operating expenses is currently $3.80 million, with the most recent change of +$102.00 thousand (+2.76%) on 01 September 2024. Over the past year, it has dropped by -$59.00 thousand (-1.53%). PSTV quarterly operating expenses is now -66.83% below its all-time high of $11.45 million, reached on 31 December 2013.PSTV Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -1.5% |
| 3 y3 years | +34.7% | +9.1% |
| 5 y5 years | +13.4% | +81.7% |
PSTV Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -32.4% | +34.7% | -31.8% | +155.0% |
| 5 y | 5 years | -32.4% | +34.7% | -31.8% | +172.1% |
| alltime | all time | -68.4% | +547.6% | -66.8% | +172.1% |
Plus Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.80 M(+2.8%) |
| June 2024 | - | $3.70 M(+12.1%) |
| Mar 2024 | - | $3.30 M(-14.5%) |
| Dec 2023 | $13.32 M(-32.4%) | $3.86 M(+18.7%) |
| Sept 2023 | - | $3.25 M(+118.2%) |
| June 2023 | - | $1.49 M(-68.4%) |
| Mar 2023 | - | $4.72 M(-15.3%) |
| Dec 2022 | $19.71 M(+58.6%) | $5.57 M(+9.4%) |
| Sept 2022 | - | $5.09 M(-0.5%) |
| June 2022 | - | $5.12 M(+30.4%) |
| Mar 2022 | - | $3.93 M(+0.9%) |
| Dec 2021 | $12.43 M(+25.7%) | $3.89 M(+11.8%) |
| Sept 2021 | - | $3.48 M(+35.2%) |
| June 2021 | - | $2.58 M(+3.9%) |
| Mar 2021 | - | $2.48 M(-27.0%) |
| Dec 2020 | $9.89 M(-7.2%) | $3.40 M(+143.2%) |
| Sept 2020 | - | $1.40 M(-45.0%) |
| June 2020 | - | $2.54 M(-0.9%) |
| Mar 2020 | - | $2.56 M(-24.8%) |
| Dec 2019 | $10.65 M(-9.3%) | $3.40 M(+62.6%) |
| Sept 2019 | - | $2.09 M(+6.7%) |
| June 2019 | - | $1.96 M(-32.5%) |
| Mar 2019 | - | $2.90 M(-40.7%) |
| Dec 2018 | $11.74 M(-54.4%) | $4.89 M(+119.7%) |
| Sept 2018 | - | $2.23 M(-47.6%) |
| June 2018 | - | $4.25 M(-25.8%) |
| Mar 2018 | - | $5.73 M(+18.5%) |
| Dec 2017 | $25.78 M(-10.9%) | $4.83 M(-18.6%) |
| Sept 2017 | - | $5.93 M(-11.2%) |
| June 2017 | - | $6.68 M(-19.8%) |
| Mar 2017 | - | $8.33 M(+39.3%) |
| Dec 2016 | $28.92 M(-8.0%) | $5.98 M(-12.6%) |
| Sept 2016 | - | $6.85 M(-19.9%) |
| June 2016 | - | $8.55 M(+13.2%) |
| Mar 2016 | - | $7.55 M(+2.8%) |
| Dec 2015 | $31.43 M(-16.1%) | $7.34 M(+0.8%) |
| Sept 2015 | - | $7.29 M(-23.2%) |
| June 2015 | - | $9.49 M(+30.1%) |
| Mar 2015 | - | $7.30 M(+5.7%) |
| Dec 2014 | $37.46 M(-11.1%) | $6.91 M(-21.4%) |
| Sept 2014 | - | $8.79 M(-21.6%) |
| June 2014 | - | $11.21 M(+6.2%) |
| Mar 2014 | - | $10.56 M(-7.8%) |
| Dec 2013 | $42.12 M(+8.6%) | $11.45 M(+11.8%) |
| Sept 2013 | - | $10.24 M(-3.4%) |
| June 2013 | - | $10.61 M(+8.0%) |
| Mar 2013 | - | $9.82 M(-4.4%) |
| Dec 2012 | $38.79 M | $10.28 M(+5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $9.78 M(+2.0%) |
| June 2012 | - | $9.59 M(+5.0%) |
| Mar 2012 | - | $9.14 M(+8.1%) |
| Dec 2011 | $39.19 M(+17.7%) | $8.45 M(-15.4%) |
| Sept 2011 | - | $9.99 M(-8.7%) |
| June 2011 | - | $10.93 M(+11.4%) |
| Mar 2011 | - | $9.82 M(-12.6%) |
| Dec 2010 | $33.30 M(+1.3%) | $11.23 M(+9.5%) |
| Sept 2010 | - | $10.26 M(+63.9%) |
| June 2010 | - | $6.26 M(+12.6%) |
| Mar 2010 | - | $5.55 M(-50.5%) |
| Dec 2009 | $32.88 M(-5.4%) | $11.22 M(+59.7%) |
| Sept 2009 | - | $7.03 M(-14.2%) |
| June 2009 | - | $8.19 M(+27.3%) |
| Mar 2009 | - | $6.44 M(-18.9%) |
| Dec 2008 | $34.76 M(+9.6%) | $7.93 M(-13.1%) |
| Sept 2008 | - | $9.13 M(+0.3%) |
| June 2008 | - | $9.10 M(+8.1%) |
| Mar 2008 | - | $8.42 M(-22.1%) |
| Dec 2007 | $31.72 M(+23.6%) | $10.81 M(+20.4%) |
| Sept 2007 | - | $8.98 M(+39.7%) |
| June 2007 | - | $6.43 M(-27.4%) |
| Mar 2007 | - | $8.86 M(+323.5%) |
| Dec 2006 | $25.67 M(-15.8%) | $2.09 M(-75.7%) |
| Sept 2006 | - | $8.62 M(+16.9%) |
| June 2006 | - | $7.37 M(-2.8%) |
| Mar 2006 | - | $7.59 M(-25.8%) |
| Dec 2005 | $30.48 M(+61.3%) | $10.23 M(+20.0%) |
| Sept 2005 | - | $8.52 M(+38.5%) |
| June 2005 | - | $6.15 M(+11.1%) |
| Mar 2005 | - | $5.54 M(+29.8%) |
| Dec 2004 | $18.89 M(-0.8%) | $4.27 M(-13.2%) |
| Sept 2004 | - | $4.92 M(-1.2%) |
| June 2004 | - | $4.98 M(+5.0%) |
| Mar 2004 | - | $4.74 M(+3.1%) |
| Dec 2003 | $19.05 M(+8.9%) | $4.59 M(-16.2%) |
| Sept 2003 | - | $5.48 M(+28.2%) |
| June 2003 | - | $4.27 M(-9.2%) |
| Mar 2003 | - | $4.71 M(-25.5%) |
| Dec 2002 | $17.50 M(+19.2%) | $6.32 M(+62.3%) |
| Sept 2002 | - | $3.90 M(+9.9%) |
| June 2002 | - | $3.54 M(-5.2%) |
| Mar 2002 | - | $3.74 M(+15.2%) |
| Dec 2001 | $14.68 M(+9.0%) | $3.24 M(-17.9%) |
| Sept 2001 | - | $3.95 M(-6.5%) |
| June 2001 | - | $4.23 M |
| Dec 2000 | $13.47 M(+144.7%) | - |
| Dec 1999 | $5.50 M(+167.5%) | - |
| Dec 1998 | $2.06 M | - |
FAQ
- What is Plus Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Plus Therapeutics?
- What is Plus Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Plus Therapeutics?
- What is Plus Therapeutics quarterly operating expenses year-on-year change?
What is Plus Therapeutics annual total operating expenses?
The current annual operating expenses of PSTV is $13.32 M
What is the all time high annual operating expenses for Plus Therapeutics?
Plus Therapeutics all-time high annual total operating expenses is $42.12 M
What is Plus Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of PSTV is $3.80 M
What is the all time high quarterly operating expenses for Plus Therapeutics?
Plus Therapeutics all-time high quarterly total operating expenses is $11.45 M
What is Plus Therapeutics quarterly operating expenses year-on-year change?
Over the past year, PSTV quarterly total operating expenses has changed by -$59.00 K (-1.53%)